Researchers reported a 60-fold boost in the performance of a compact CRISPR nuclease after engineering changes to the enzyme and guide RNA design. The work, published in Molecular Systems Biology, centers on CgCas12n, aiming to improve gene-editing potency in human cells while preserving the benefits of using a smaller CRISPR system.